Literature DB >> 14556072

Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix.

Isamu Hayashi1, Hitoshi Tsuda, Tadakazu Shimoda, Arafumi Maeshima, Takahiro Kasamatsu, Takuro Yamada, Ryuichiro Tsunematsu.   

Abstract

To investigate whether the cytoplasmic localization pattern of neutral mucin differs between lobular endocervical glandular hyperplasia (LEGH) and cervical adenocarcinoma (CxAd), including minimal-deviation adenocarcinoma (MDA), or adenoma malignum, alcian blue (pH 2.5)/periodic acid-Schiff (AB-PAS) staining was performed to formalin-fixed paraffin-embedded tissue sections of 13 lesions of LEGH and 53 tumors of CxAd, including 6 tumors of MDA. The cytoplasmic localization of neutral mucin was classified as a "whole cytoplasmic pattern," in which neutral mucin filled the cytoplasm entirely, or as an "apical pattern," in which neutral mucin was localized in the subsurface area only. Cytoplasmic neutral mucin patterns were detected in all 13 cases of LEGH and in 19 cases (36%) of CxAd, including five cases of MDA. The localization of neutral mucin was always the whole cytoplasmic pattern in 13 cases of LEGH, but was the apical pattern in these 19 cases of CxAd. The other 34 cases of CxAd, including 1 case of MDA, corresponded to the acid mucin pattern stained purple or blue or no staining pattern by AB-PAS. Among the 53 cases of CxAd, the apical neutral mucin pattern was an indicator of poorer patient prognosis by univariate and multivariate analyses. The examination of cytoplasmic localization of neutral mucin might be applicable, not only to differential diagnosis between LEGH and CxAd, including MDA, but also to estimate clinical aggressiveness of CxAd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556072     DOI: 10.1007/s00428-003-0899-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  Diffuse laminar endocervical glandular hyperplasia. A benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma).

Authors:  M A Jones; R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

2.  Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum.

Authors:  M R Nucci; P B Clement; R H Young
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

3.  Adenocarcinoma of the endocervix--a histochemical study.

Authors:  P Cooper; G Russell; B Wilson
Journal:  Histopathology       Date:  1987-12       Impact factor: 5.087

4.  Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix.

Authors:  I Hayashi; H Tsuda; T Shimoda
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

5.  Endocervical and endometrial adenocarcinoma: an immunoperoxidase and histochemical study.

Authors:  C Cohen; G Shulman; L R Budgeon
Journal:  Am J Surg Pathol       Date:  1982-03       Impact factor: 6.394

6.  Diagnostic significance of endocervical glandular cells with "golden-yellow" mucin on pap smear.

Authors:  Sakae Hata; Yoshiki Mikami; Toshiaki Manabe
Journal:  Diagn Cytopathol       Date:  2002-08       Impact factor: 1.582

7.  Minimal deviation adenocarcinoma of the uterine cervix ("adenoma malignum"). An immunohistochemical comparison with microglandular endocervical hyperplasia and conventional endocervical adenocarcinoma.

Authors:  T A Steeper; M R Wick
Journal:  Cancer       Date:  1986-09-01       Impact factor: 6.860

8.  Adenomyomas of the uterine cervix of of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected].

Authors:  C B Gilks; R H Young; P B Clement; W R Hart; R E Scully
Journal:  Mod Pathol       Date:  1996-03       Impact factor: 7.842

9.  Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases.

Authors:  C B Gilks; R H Young; P Aguirre; R A DeLellis; R E Scully
Journal:  Am J Surg Pathol       Date:  1989-09       Impact factor: 6.394

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.